Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Köster, , Louise,
DOB: 01-JUL-1957 (Age: 68)
Gender: female
ID: 1053-167357-1 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 10-DEC-2024

Problem list

Condition Onset Date Status
Prediabetes 29-Aug-2006 active
Metabolic syndrome X 29-Aug-2006 active
Ischemic heart disease 08-Jul-1997 active
Essential hypertension 07-Apr-1981 active

Medication list

Medication Since Form Dosage Reason
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2024-12-10 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2024-12-10 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2024-12-10 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 1997-07-15 - 1 tablet (75 mg) once daily -
Simvastatin 20 mg oral tablet 1997-07-15 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 1997-07-15 - 400 micrograms per spray, use one spray under the tongue as needed for chest pain, repeat every 5 minutes if needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 1997-07-15 - 1 tablet (100 mg) once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 10-Dec-2024
Streptococcus pneumoniae Danish serotype 1 29-Nov-2022
Streptococcus pneumoniae Danish serotype 1 23-Nov-2021
SARS-CoV-2 mRNA vaccine 13-Apr-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 31-Oct-2017

Procedure History list

Procedure Date Reason
Pelvis X-ray 18-Aug-2016 -
Admission to orthopedic department 18-Aug-2016 Closed fracture of hip
Bone density scan 18-Aug-2016 Closed fracture of hip

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Diabetes self management plan 29-Aug-2006 Prediabetes
  • Maintain hemoglobin A1c below 5.7% to reduce risk of diabetes progression.
  • Achieve and maintain a 5% reduction in body weight to improve metabolic syndrome and prediabetes.
  • Maintain blood pressure below 130/80 mmHg to reduce cardiovascular risk.
  • Maintain LDL cholesterol below 100 mg/dL to reduce cardiovascular risk.
Lifestyle education regarding hypertension 07-Apr-1981 Essential hypertension (disorder)
  • Patient will achieve and maintain target blood pressure through lifestyle education and interventions for hypertension.
  • Patient will achieve weight reduction as part of lifestyle modification for hypertension management.
  • Patient will engage in at least 150 minutes of moderate-intensity physical activity per week to support blood pressure control.
  • Patient will reduce dietary sodium intake to recommended levels to support blood pressure control.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2024-12-10 2023-12-05
Body Height 162.8 cm 162.8 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 2 {score}
Body Weight 81.1 kg 81.1 kg
Body mass index (BMI) [Ratio] 30.6 kg/m2 30.6 kg/m2
Diastolic Blood Pressure 75 mm[Hg] 76 mm[Hg]
Systolic Blood Pressure 107 mm[Hg] 111 mm[Hg]
Heart rate 92 /min 77 /min
Respiratory rate 16 /min 13 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 10-DEC-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 72.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.7 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.7 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 137.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.2 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.4 22 - 32 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 29-Aug-2006